Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors ...

Transatlantic trailblazer Nuclera, a biotech company with homes in Cambridge UK and Boston in the US, continues to create new ...

Emerging evidence links popular weight-loss drugs to lower cancer rates, but are these effects real, or simply a reflection of better metabolic health?

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

Monash University's Professor Arthur Christopoulos has earned a prestigious 2025 Research Excellence Award from the National ...

Ambrosia Biosciences is aiming to move the market beyond peptide-based obesity treatments and initiate a trial for its oral ...

Monash University's Professor Arthur Christopoulos, FAA, FAHMS, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, has been honoured with a ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2025, and ...

An international team, including scientists from Leipzig University, has gained important new insights into the regulation of ...

An international team, including scientists from Leipzig University, has gained important new insights into the regulation of food intake in mammals. The study, recently published in the renowned ...

His research showed that Type 2 diabetes was caused by insulin resistance at the cellular level, a controversial idea that ...

Ambrosia Biosciences. The financing provides $100 million in committed capital, intended to fund the Company through clinical ...